EP1144640A3 - Acides nucleiques et proteines de streptococcus pneumoniae - Google Patents

Acides nucleiques et proteines de streptococcus pneumoniae

Info

Publication number
EP1144640A3
EP1144640A3 EP99934990A EP99934990A EP1144640A3 EP 1144640 A3 EP1144640 A3 EP 1144640A3 EP 99934990 A EP99934990 A EP 99934990A EP 99934990 A EP99934990 A EP 99934990A EP 1144640 A3 EP1144640 A3 EP 1144640A3
Authority
EP
European Patent Office
Prior art keywords
proteins
nucleic acids
streptococcus pneumoniae
pneumoniae
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99934990A
Other languages
German (de)
English (en)
Other versions
EP1144640A2 (fr
Inventor
Richard William Falla Le Page
Jeremy Mark Actinova Ltd. WELLS
Sean Bosco Hanniffy
Philip Michael CBVT Dis. Immun.Microbio HANSBRO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Technics Ltd
Original Assignee
Microbial Technics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816336.3A external-priority patent/GB9816336D0/en
Application filed by Microbial Technics Ltd filed Critical Microbial Technics Ltd
Priority to EP07000680A priority Critical patent/EP1801218A3/fr
Priority to EP05019268A priority patent/EP1624064A3/fr
Publication of EP1144640A2 publication Critical patent/EP1144640A2/fr
Publication of EP1144640A3 publication Critical patent/EP1144640A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP99934990A 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae Withdrawn EP1144640A3 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07000680A EP1801218A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de la pneumonie à streptocoques
EP05019268A EP1624064A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de streptococcus pneumoniae

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9816336 1998-07-27
GBGB9816336.3A GB9816336D0 (en) 1998-07-27 1998-07-27 Proteins
US12532999P 1999-03-19 1999-03-19
US125329P 1999-03-19
PCT/GB1999/002452 WO2000006738A2 (fr) 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05019268A Division EP1624064A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
EP1144640A2 EP1144640A2 (fr) 2001-10-17
EP1144640A3 true EP1144640A3 (fr) 2001-11-28

Family

ID=26314124

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99934990A Withdrawn EP1144640A3 (fr) 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae

Country Status (4)

Country Link
EP (1) EP1144640A3 (fr)
JP (2) JP2002521058A (fr)
CN (1) CN1318103A (fr)
WO (1) WO2000006738A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CA2341268C (fr) 1998-07-22 2010-10-12 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Vaccins contre le streptococcus suis et tests diagnostiques
EP1950302B1 (fr) * 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Nouveaux antigènes de streptocoque
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
WO2000076540A2 (fr) * 1999-06-10 2000-12-21 Med Immune, Inc. Proteines et vaccins de streptococcus pneumoniae
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
DE10012370A1 (de) * 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EP1205552A1 (fr) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence de streptococci, avec ORFs de Streptococcus suis
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0108079D0 (en) * 2001-03-30 2001-05-23 Microbial Technics Ltd Protein
EP1456231A2 (fr) 2001-12-20 2004-09-15 Shire Biochem Inc. Antigenes de streptococcus
AU2003286056A1 (en) * 2002-11-26 2004-06-18 Id Biomedical Corporation Streptococcus pneumoniae surface polypeptides
EP2333114A1 (fr) * 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigènes
DK3466982T3 (da) * 2005-04-08 2020-08-03 Wyeth Llc Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
ES2546213T3 (es) 2008-03-03 2015-09-21 Novartis Ag Compuestos y composiciones como moduladores de la actividad de TLR
CN101977927A (zh) * 2008-03-17 2011-02-16 英特塞尔股份公司 针对肺炎链球菌保护的肽以及与其有关的组合物、方法和用途
EP2218457B1 (fr) * 2009-02-16 2011-09-07 Karlsruher Institut für Technologie Peptides CD44v6 en tant qu'inhibiteurs d'infections bactériennes
CA2765112A1 (fr) 2009-06-10 2010-12-16 Novartis Ag Vaccins contenant de la benzonaphtyridine
CN107126557A (zh) 2009-06-29 2017-09-05 健诺西生物科学公司 抗肺炎链球菌的疫苗和组合物
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
WO2011030218A1 (fr) 2009-09-10 2011-03-17 Novartis Ag Vaccins combinés contre les maladies des voies respiratoires
WO2011057148A1 (fr) 2009-11-05 2011-05-12 Irm Llc Composés et compositions permettant de moduler l'activité des tlr-7
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
EP3165531B1 (fr) 2010-03-12 2020-11-25 Children's Medical Center Corporation Composition immunogène, vaccin et leurs utilisations
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2012072769A1 (fr) 2010-12-01 2012-06-07 Novartis Ag Epitopes rrgb de pneumocoque et combinaisons de variantes
WO2012100234A1 (fr) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccins et compositions contre streptococcus pneumoniae
CN104519910B (zh) 2012-03-07 2017-05-03 诺华股份有限公司 肺炎链球菌抗原的含佐剂制剂
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
CA2900008C (fr) 2013-02-07 2025-10-07 Children's Medical Center Corporation Antigenes de proteine qui conferent une protection contre une colonisation et/ou une maladie pneumococcique
CN103834667B (zh) * 2013-12-31 2016-08-17 李越希 化学合成的肺炎链球菌PspA蛋白胞外区基因片段及其表达、应用
PL3752182T3 (pl) 2018-02-12 2024-11-25 Inimmune Corporation Ligandy receptorów toll-podobnych
IL281204B2 (en) 2018-09-12 2025-07-01 Affinivax Inc Multivalent pneumococcal vaccines
TWI852943B (zh) * 2018-09-12 2024-08-21 美商兒童醫療中心公司 肺炎鏈球菌融合蛋白疫苗
CA3198876A1 (fr) 2020-11-04 2022-05-12 Eligo Bioscience Phages recombinants de cutibacterium acnes, leur procede de production et leurs utilisations
AU2022342080A1 (en) 2021-09-09 2024-03-28 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
WO1997037026A1 (fr) * 1996-04-02 1997-10-09 Smithkline Beecham Corporation Nouveaux composes
WO1997043304A1 (fr) * 1996-05-14 1997-11-20 Smithkline Beecham Corporation Composes de type nouveau
CA2271720A1 (fr) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Polynucleotides et sequences de streptococcus pneumoniae
US6271000B1 (en) * 1996-12-13 2001-08-07 Eli Lilly And Company Streptococcus pneumoniae gene sequence mraY
GB9700939D0 (en) * 1997-01-17 1997-03-05 Microbial Technics Limited Therapy

Also Published As

Publication number Publication date
JP2008022856A (ja) 2008-02-07
CN1318103A (zh) 2001-10-17
WO2000006738A3 (fr) 2001-08-23
EP1144640A2 (fr) 2001-10-17
JP2002521058A (ja) 2002-07-16
WO2000006738A2 (fr) 2000-02-10

Similar Documents

Publication Publication Date Title
AU2002309130A1 (en) Streptococcus pneumoniae proteins and nucleic acids
AU2002214127A1 (en) Nucleic acids and proteins from streptococcus groups A and B
AU5793798A (en) Streptococcus pneumoniae dna sequences
WO1999046281A8 (fr) Nouveaux polypeptides et acides nucleiques les codant
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2001269039A1 (en) Immobilized nucleic acids and uses thereof
AU2486300A (en) Secreted proteins and nucleic acids encoding them
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU6280899A (en) Secreted proteins and nucleic acids encoding them
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU3511100A (en) Novel nucleic acids and polypeptides
AU6164099A (en) Hrpca 9 and hrpca 10 nucleic acids and polypeptides
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU5377599A (en) Nucleic acids
AU7756100A (en) Interleukin-2 like protein and nucleic acids encoding same
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU1690200A (en) Novel protein and dna thereof
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
AU5447999A (en) Novel protein and dna thereof
AU2017201090B2 (en) Nucleic acids and proteins from streptococcus groups A & B
AU2017201090A1 (en) Nucleic acids and proteins from streptococcus groups A & B
AU2381700A (en) Ndsp nucleic acids and polypeptides
AU2002313838A1 (en) Novel PRO866 polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20010227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20050223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050906